Lacerta Therapeutics, Inc. — Form D
Lacerta Therapeutics, Inc. of ALACHUA, FL, a company, filed a Form D exempt-offering notice with the SEC on 2018-08-07. The offering totals $500K, of which $500K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-08-07
- Form: D
- Accession: 0000897069-18-000495
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $500K
- Investors: 6
- Date of first sale: 2017-06-27
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-318605
Issuer
- Name: Lacerta Therapeutics, Inc.
- CIK: 0001748465
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 12085 RESEARCH DRIVE, ALACHUA, FL, 32615
- Phone: (352) 514-7669
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| James D Rusche | Director | Alachua, FL |
| Nicholas D Muzyczka | Director | Alachua, FL |
| Joseph D Reddy | Director | Alachua, FL |
| Joseph D Reddy | Executive Officer | Alachua, FL |
| Joseph D Reddy | Promoter | Alachua, FL |
| Barry D Byrne | Director | Alachua, FL |
| Barry D Byrne | Promoter | Alachua, FL |
| Kenneth D Warrington | Executive Officer | Alachua, FL |
| Kenneth D Warrington | Promoter | Alachua, FL |
| Sergei D Zolotukhin | Director | Alachua, FL |
| Sergei D Zolotukhin | Promoter | Alachua, FL |
Other filings by this issuer (1)
More